BlackRock Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$374M Sell
5,253,931
-539,802
-9% -$42.4M 0.38% 60
2016
Q3
$501M Sell
5,793,733
-461,358
-7% -$40.2M 0.52% 41
2016
Q2
$543M Buy
6,255,091
+364,105
+6% +$29.4M 0.55% 37
2016
Q1
$442M Buy
5,890,986
+408,759
+7% +$30.8M 0.46% 47
2015
Q4
$422M Buy
5,482,227
+357,174
+7% +$26.9M 0.45% 54
2015
Q3
$343M Buy
5,125,053
+638,312
+14% +$47M 0.37% 71
2015
Q2
$332M Sell
4,486,741
-1,990,918
-31% -$152M 0.35% 80
2015
Q1
$505M Buy
6,477,659
+1,483,283
+30% +$112M 0.52% 44
2014
Q4
$361M Sell
4,994,376
-767,860
-13% -$53.3M 0.36% 67
2014
Q3
$357M Sell
5,762,236
-1,677,124
-23% -$107M 0.36% 65
2014
Q2
$474M Sell
7,439,360
-120,369
-2% -$7.31M 0.45% 49
2014
Q1
$465M Sell
7,559,729
-880,925
-10% -$51.3M 0.46% 49
2013
Q4
$484M Sell
8,440,654
-180,749
-2% -$10.2M 0.47% 51
2013
Q3
$459M Buy
8,621,403
+2,638,086
+44% +$142M 0.46% 56
2013
Q2
$308M Buy
+5,983,317
New +$296M 0.32% 78

Other funds holding MDT

BlackRock Advisors's MDT Position: Q4 2016 in Review

BlackRock Advisors reduced its Medtronic (MDT) stake by 9.3% in Q4 2016, selling an estimated $42.4M and leaving 5,253,931 shares worth $374M. The position accounts for 0.38% of the portfolio, ranked #60.

BlackRock Advisors first reported a position in MDT in Q2 2013 and has held it in 15 quarters since. The position peaked at $543M in Q2 2016. 1,268 funds tracked by Wall St. Rank hold MDT as of Q4 2016.

  • BlackRock Advisors held 5,253,931 shares of Medtronic worth $374M as of Q4 2016.
  • BlackRock Advisors sold 539,802 Medtronic shares in Q4 2016, an estimated $42.4M.
  • Medtronic made up 0.38% of BlackRock Advisors's portfolio in Q4 2016, its #60 holding.
  • BlackRock Advisors first reported a position in Medtronic in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Medtronic position peaked at $543M in Q2 2016.
  • 1,268 funds tracked by Wall St. Rank held Medtronic as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.